Hexagon Capital Partners’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-159	Closed	-$29.4K	–	1852
2024 Q4	$29.4K	Buy	+159	New	+$30.6K	0.01%	651
2024 Q2	–	Sell	-4	Closed	-$1.08K	–	1473
2024 Q1	$1.08K	Sell	4 -8	-67%	-$1.91K	﹤0.01%	1264
2023 Q4	$2.84K	Hold	12	–	–	﹤0.01%	1072
2023 Q3	$2.35K	Hold	12	–	–	﹤0.01%	1040
2023 Q2	$2.52K	Hold	12	–	–	﹤0.01%	1035
2023 Q1	$2.42K	Sell	12 -19	-61%	-$4.31K	﹤0.01%	1033
2022 Q4	$6.75K	Hold	31	–	–	﹤0.01%	834
2022 Q3	$6K	Buy	31 +6	+24%	+$1.29K	﹤0.01%	885
2022 Q2	$5K	Hold	25	–	–	﹤0.01%	791
2022 Q1	$7K	Hold	25	–	–	﹤0.01%	659
2021 Q4	$9K	Hold	25	–	–	﹤0.01%	611
2021 Q3	$10K	Hold	25	–	–	﹤0.01%	589
2021 Q2	$9K	Sell	25 -15	-38%	-$5.01K	﹤0.01%	572
2021 Q1	$11K	Sell	40 -6	-13%	-$1.67K	﹤0.01%	511
2020 Q4	$11K	Hold	46	–	–	﹤0.01%	471
2020 Q3	$10K	Buy	+46	New	+$9.55K	﹤0.01%	451